Therapeutic adherence in vulnerable chronic patients using personalised dosage systems in community pharmacy in Región de Murcia

Authors

  • María Jesús Rodríguez Arcas Colegio Oficial de Farmacéuticos de la Región de Murcia, Murcia, España https://orcid.org/0000-0002-1320-4219
  • José Juan González García-Arquimbau Colegio Oficial de Farmacéuticos de la Región de Murcia, Murcia, España
  • África García Jiménez Colegio Oficial de Farmacéuticos de la Región de Murcia, Murcia, España https://orcid.org/0009-0002-3125-7143
  • María José Cecilia Reche Colegio Oficial de Farmacéuticos de la Región de Murcia, Murcia, España https://orcid.org/0009-0000-6913-7281
  • Beatriz Jurado Obis Ayuntamiento de Cartagena, Cartagena, España
  • Ana Belén Martínez Aguado Cruz Roja Española, Murcia, España

DOI:

https://doi.org/10.60103/phc.v28.e944

Keywords:

Medication adherence, Chronic disease, Pharmaceutical Care Professional Services, Medication dosing systems, Vulnerable populations

Abstract

Objective: To evaluate the implementation and outcomes of a medication adherence programme based on the provision of Pharmaceutical Care Services to vulnerable patients with chronic conditions in the municipalities of Cartagena and San Javier (Region of Murcia, Spain).

Methods: A descriptive observational study conducted in community pharmacies trained in Pharmaceutical Care Services and registered with Nodofarma Asistencial. Patients with chronic conditions experiencing economic and/or social vulnerability, referred by healthcare and social services and meeting predefined economic and health-related criteria, were included. The intervention combined a Medication Adherence Service (patient interview, medication review, adherence assessment and quality-of-life assessment using the EuroQol EQ-5D-5L and visual analogue scale) with weekly medication repackaging into Personalised Medication Dosage Systems (PMDS), with monthly follow-up at the pharmacy. The Red Cross provided social support through fortnightly telephone calls and home visits, while the municipal councils funded the project.

Results: A total of 67 patients were included during the study period, with 669 visits recorded in Nodofarma Asistencial as part of the Medication Adherence Service. The proportion of patients classified as adherent at the end of follow-up was 69.05%, and the mean quality-of-life score increased by 12.2%. A total of 25 drug-related problems (DRPs) were identified, of which 69.5% were resolved, with drug interactions being the most frequent. These resulted in 25 potential negative medication-related outcomes (NMOs), the most frequent being non-quantitative medication safety problems. A total of 2,206 remunerated PMDS units were prepared, at a reimbursement rate of €36.52 per patient per month. Arterial hypertension was the most prevalent condition, and forgetfulness was the main cause of non-adherence.

Conclusions: The combination of a structured medication adherence service and personalised medication dosage systems delivered through community pharmacies, in coordination with social services, improves medication adherence and perceived health status among vulnerable patients with chronic conditions and facilitates the identification and resolution of relevant pharmacotherapeutic and social problems.

Downloads

Download data is not yet available.

Author Biography

María Jesús Rodríguez Arcas, Colegio Oficial de Farmacéuticos de la Región de Murcia, Murcia, España

She holds a degree in Pharmacy with a specialisation in Biochemistry from the Complutense University of Madrid and a PhD cum laude in Drug Development  from the University of Granada.

She is currently Vice-President of the Official College of Pharmacists (the statutory professional body for pharmacists) of the Region of Murcia, Spain and Technical Director of the School of Professional Pharmacy Practice at the University of Murcia. She also owns and manages a community pharmacy, where she provides medicines dispensing, extemporaneous compounding, and pharmacotherapeutic follow-up services.

Her postgraduate training includes Genomic Medicine, Genetic Counselling, Pharmacovigilance, Personalised Medicines Compounding, and Pharmacogenetics in Pharmaceutical Care. She has extensive teaching experience in postgraduate and continuing professional education, and has supervised doctoral and undergraduate research projects.

Scientific and technological experience includes participation in competitive publicly and privately funded R&D&I projects, including pharmacogenetic researchin patients treated with statins.

References

Ministerio de Sanidad. Principales problemas crónicos de salud, porcentaje de población de 15 y más años que padece determinados problemas crónicos, registrado en atención primaria, por comunidad autónoma. Año 2024 [Internet]. Madrid: Ministerio de Sanidad. Disponible en: https://www.sanidad.gob.es/estadEstudios/sanidadDatos/tablas/tabla5.htm

Eurostat. Self-perceived health statistics. Statistics Explained [Internet]. Luxemburgo: Comisión Europea; 2026. Datos correspondientes a 2024. Disponible en: https://ec.europa.eu/eurostat/statistics-explained/index.php/Self-perceived_health_statistics

Instituto Nacional de Estadística. Personas con enfermedades o problemas de salud de larga duración por comunidad autónoma. Indicadores de Calidad de Vida [Internet]. Madrid: INE; actualización 31 oct 2025. Disponible en: https://www.ine.es/jaxiT3/Tabla.htm?t=69640

Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.

World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Disponible en: https://iris.who.int/items/bf8058c0-03b2-4b47-838f-5534849927fb

Parekh N, Ali K, Stevenson JM, Davies JG, Schiff R, Van der Cammen TJM, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK. Br J Clin Pharmacol. 2018;84(8):1789-1797. https://doi.org/10.1111/bcp.13613

Álvarez Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014;38(4):328-333.

Valdés y Llorca C, Barajas-Nava LA, García-Cárdenas V, Varas-Doval R, Gastelurrutia-Garralda MA, Faus MJ, et al. Factors associated with non-adherence to drugs in patients with chronic diseases who go to pharmacies in Spain. Int J Environ Res Public Health. 2021;18(8):4308. https://doi.org/10.3390/ijerph18084308

Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: a systematic scoping review. Heliyon. 2022;8(6):e09716. doi: 10.1016/j.heliyon.2022.e09716

Lu J, Zhang N, Mao D, Wang Y, Wang X. How social isolation and loneliness effect medication adherence among elderly with chronic diseases: an integrated theory and validated cross-sectional study. Arch Gerontol Geriatr. 2020;90:104154.

Torres-Novellas B, Llauradó L, Sabaté M, Pérez E, Capellà D, Amariles P, et al. Drug-related problems detected in complex chronic patients by community pharmacists of Catalonia: perception of the person-centred approach necessity. Healthcare (Basel). 2024;12(2):240.

Torres-Robles A, Wiecek E, Tonin FS, Benrimoj SI, Fernández-Llimós F, García-Cárdenas V. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf. 2022;31(2):105-115.

Moges TA, Dagnew SB, Wondm SA, Ferede YA, Yiblet TG, Almaw A, et al. Determinants of medication non-adherence among patients with chronic diseases at community pharmacy settings in South Gondar Zone, Northwest Ethiopia: a multicenter cross-sectional study. Front Public Health. 2024;12:1409153. https://doi.org/10.3389/fpubh.2024.1409153

Huang J, Wang HHX, Zheng Z, Wong MCS. Medication adherence among the older adults: challenges and recommendations. Hong Kong Med J. 2020;26(6):476-478.

Schulz RM, Porter C, Lane M, Cornman C, Branham L. Impact of a medication management system on nursing home admission rate in a community-dwelling nursing home-eligible Medicaid population. Am J Geriatr Pharmacother. 2011 Feb;9(1):69-79. doi: 10.1016/j.amjopharm.2011.02.008.

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.

Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.

Published

2026-11-17

How to Cite

Rodríguez Arcas, M. J., González García-Arquimbau, J. J., García Jiménez, África, Cecilia Reche, M. J., Jurado Obis, B., & Martínez Aguado, A. B. (2026). Therapeutic adherence in vulnerable chronic patients using personalised dosage systems in community pharmacy in Región de Murcia. Pharmaceutical Care España, 28. https://doi.org/10.60103/phc.v28.e944

Issue

Section

Originales